Atlas Capital Advisors’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-722
Closed -$5.56K 894
2023
Q1
$5.56K Sell
722
-3,576
-83% -$29K ﹤0.01% 790
2022
Q4
$39.5K Buy
4,298
+1,986
+86% +$22.1K 0.01% 577
2022
Q3
$22.5K Sell
2,312
-14,519
-86% -$181K ﹤0.01% 644
2022
Q2
$240K Buy
+16,831
New +$288K 0.04% 343

Other funds holding BAK

Atlas Capital Advisors's BAK Position: Q2 2023 in Review

Atlas Capital Advisors sold out of Braskem (BAK) in Q2 2023, closing a stake of 722 shares — an estimated $5.56K sold.

Atlas Capital Advisors first reported a position in BAK in Q2 2022 and held it in 4 quarters. The position peaked at $240K in Q2 2022. 59 funds tracked by Wall St. Rank hold BAK as of Q2 2023.

  • Atlas Capital Advisors reported no remaining Braskem position as of Q2 2023 after selling out during the quarter.
  • Atlas Capital Advisors sold 722 Braskem shares in Q2 2023, an estimated $5.56K.
  • Atlas Capital Advisors first reported a position in Braskem in Q2 2022 and held it in 4 quarters.
  • Atlas Capital Advisors's Braskem position peaked at $240K in Q2 2022.
  • 59 funds tracked by Wall St. Rank held Braskem as of Q2 2023.

Based on Atlas Capital Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.